KFF Examines How Abortion Bans, Misinformation, and State Actions May Affect Access to Contraception
Following the Supreme Court’s ruling overturning Roe v. Wade, uncertainty has emerged over whether the right to contraception could also be limited.
View the Latest: Reproductive Health
Filter
-
-
Large Shares of Black Adults, Hispanic Adults, and Rural Residents are Unsure Whether to Believe Many False Health Claims
News ReleaseDrawing on KFF’s Misinformation Pilot Poll, KFF today released three follow-up reports examining exposure to, and belief in, health misinformation among Black adults, Hispanic adults, and rural communities.
-
Addressing Misinformation in Rural Communities: Snapshot from the KFF Health Misinformation Tracking Poll Pilot
Poll FindingThis report examines the exposure to, and belief in, health misinformation among people living in rural communities, as well as the media sources they use and the trust they place in health information received from various outlets. It is a companion to the KFF Health Misinformation Tracking Poll Pilot.
-
Addressing Misinformation Among Black Adults: Snapshot from the KFF Health Misinformation Tracking Poll Pilot
Poll FindingThis report examines the exposure to, and belief in, health misinformation among Black adults, as well as the media sources they use and the trust they place in health information received from various outlets. It is a companion to the KFF Health Misinformation Tracking Poll Pilot.
-
Addressing Misinformation Among Hispanic Adults: Snapshot from the KFF Health Misinformation Tracking Poll Pilot
Poll FindingThis report examines the exposure to, and belief in, health misinformation among Hispanic adults, as well as the media sources they use and the trust they place in health information received from various outlets. It is a companion to the KFF Health Misinformation Tracking Poll Pilot.
-
KFF Examines Challenges in Navigating Coverage for Opill, the First Over-the-Counter Daily Oral Contraceptive Pill, Coming to Market Next Year
News ReleaseAs Opill—the first over-the-counter daily oral contraceptive pill in the United States—is expected to be available for purchase in early 2024, new research conducted by KFF examines barriers to its accessibility for consumers and challenges in providing insurance coverage for it.
-
Insurance Coverage of OTC Oral Contraceptives: Lessons from the Field
ReportThis report is based on 35 structured interviews conducted from January to August 2023, with nearly 80 experts and key players such as pharmacists, health plans, and state Medicaid officials involved in the coverage and provision of OTC contraception in seven states with one or more of these coverage approaches (IL, NJ, NM, NY, OR, UT, and WA). It discusses the challenges and successes in coverage under private health insurance and Medicaid and reviews policy options for operationalizing insurance coverage of non-prescribed OTC contraception such as Opill.
-
KFF Health Misinformation Tracking Poll Pilot
Poll FindingThe poll reveals that at least four in ten U.S. adults saying they’ve heard each of 10 specific false claims about COVID-19, reproductive health, and gun violence. While relatively small shares definitely believes the false claims, many more are uncertain about them. The survey also examines the public’s social and traditional media use and trust in sources of health information.
-
Poll: Most Americans Encounter Health Misinformation, and Most Aren’t Sure Whether It’s True or False
News ReleaseA new KFF survey reveals the broad reach of health misinformation, with at least four in 10 people saying that they’ve heard each of 10 specific false claims about COVID-19, reproductive health, and gun violence.
-
Medicaid Expansion Has Had Beneficial Effects on Some Sexual and Reproductive Health Outcomes
News ReleaseA new KFF review of more than three dozen studies published between April 2021 and June 2023 finds that Medicaid expansion under the Affordable Care Act is associated with beneficial effects on a range of sexual and reproductive health outcomes.